High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma

Clinical trial NCT00761384 · COMPLETED

Trial details

NCT number: NCT00761384
Sponsor: Lund University Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Lymphoma

Start date: 2008-04-01
Primary completion: 2016-01-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.